Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
Dr Mohit Bhandari remotely conducted a complex robotic gastrojejunostomy from Perth using the indigenous SSI Mantra Surgical Robotic System
The private funding rose 38% amid growing international collaborations and CDMO demand
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Subscribe To Our Newsletter & Stay Updated